Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin;Dépistage du carcinome hépatocellulaire dans une cohorte de malades porteurs d'une cirrhose d'origine principalement alcoolique

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 5, 2003, Pages 534-539

  Henrion, Jean ^a   Libon, Ernest ^b   De Maeght, Stéphane ^b   Deltenre, Pierre ^b   Schapira, Michaël ^b   Ghilain, Jean Michel ^b   Maisin, Jean Marc ^b   Heller, Francis R ^b  

^a Hospital de Jolimont   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER SCREENING; DEATH; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BIOPSY; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; ULTRASONOGRAPHY;

EID: 0038340887     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chalasani N, Said A, Ness R, Hoen H, Lawrence L. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol 1999;94:2224-9.
2. Ganne-Carrié N, Chevret S, Barbare J-C, Chaffaud C, Grando V, Vogt AM, et al. Dépistage et traitement précoce du carcinome hépatocellulaire. Enquête concernant les intentions des hépato-gastroentérologues hospitaliers en France. Gastroenterol Clin Biol 2002;26:570-7.
3. Di Bisceglie AM, Carithers RL, Gores GJ. Hepatocellular carcinoma. Hepatology 1998;28:1161-5.
4. Beaugrand M. Dépistage du carcinome hépatocellulaire sur cirrhose. Gastroenterol Clin Biol 2000;24:B92-B94.
5. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
6. Cottone M, Turri M, Caltagirone M, Parisi P, Orland A, Fiorentino G. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafoetoprotein. J Hepatol 1994;21:1029-34.
7. Imberti D, Fornari F, Sbolli G, Buscarini E, Squassante L, Buscarini L. Hepatocellular carcinoma in liver cirrhosis. A prospective study. Scand J Gastroenterol 1993;28:540-4.
8. Solmi L, Manila Primerano Am, Gandolfi L. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results in a prospective study on 360 cases. Am J Gastroenterol 1996;91:1189-94.
9. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001;48:251-9.
10. Trevisani F, Denotariis S, Rapaccini G, Farinati F, Benvegnu L, Zoli M, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002;97:734-44.
11. Chalasani N, Horlander JC, Said A, Hoen H, Kopecky KK, Stockberger SM, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999;94:2988-93.
12. Henrion J, Libon E, De Maeght S, Schapira M, Ghilain JM, Maisin JM, et al. Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients. Acta Gastroenterol Belg 2000;63:5-9.
13. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in caucasian patients with cirrhosis. J Hepatol 1994;20:65-71.
14. Vilgrain V, Mathieu D, Trinchet JC. Dépistage du carcinome hépatocellulaire sur cirrhose: participation à une large étude multicentrique frangaise (CHC 2000). J Radiol 2000;81:1567-88.
15. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-30.
16. Trinchet JC, Beaugrand M. Dépistage du carcinome hépatocellulaire sur cirrhose. Presse Med 2001;30:1164-9.
17. The Cancer of the Liver Italian Program (CLIP) investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000;31:840-5.
18. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-38.
19. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors of hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
20. Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with clinical Child-Pugh A cirrhosis. Am J Med 1996;177:422-34.
21. Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J. Tumor size determine the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992;16:353-7.
22. Zoli M, Magalotti D, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996;78:977-85.